Drug Profile
Olanzapine/ondansetron
Alternative Names: Ondansetron/olanzapine; TO-2060Latest Information Update: 11 Feb 2009
Price :
$50
*
At a glance
- Originator TransOral Pharmaceuticals
- Class Benzodiazepines; Carbazoles; Imidazoles; Small molecules
- Mechanism of Action Dopamine D1 receptor antagonists; Dopamine D2 receptor antagonists; Serotonin 3 receptor antagonists; Serotonin 5-HT2 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Alcoholism
Most Recent Events
- 02 Feb 2009 Novacea has merged with Transcept Pharmaceuticals to form Transcept Pharmaceuticals Inc
- 08 May 2008 Interim efficacy data from a phase I trial in Alcoholism presented at the 161st Annual Meeting of the American Psychiatric Association (APA-2008)
- 22 Jun 2007 Phase-I clinical trials in Alcoholism in USA (unspecified route)